Tagipmet XR Tablet 100/1000mg

Description

Indications

• Tagipmet XR 100/1000mg (HCI) is primarily indicated in conditions like Diabetes mellitus, Hyperlipoproteinaemia, Insulin dependent diabetes mellitus, Insulin resistance, Non-insulin dependent diabetes mellitus, Obesity.

Contraindication

• Tagipmet XR 100/1000mg (HCI) is contraindicated in conditions like Alcohol dependence, Anaemia, Myocardial infarction, Septicaemia, Infections, Respiratory disease,Ketosis, Cardiovascular disease, Diabetic coma, Trauma, Liver damage,Iron deficiency,Vitamin B12 deficiency, Renal impairment,Diabetic retinopathy.

Side Effects

• The severe or irreversible adverse effects of Tagipmet XR 100/1000mg (HCI), which give rise to further complications include Vasculitis, Pneumonitis, Malabsorption of vit B12, Malabsorpton of folic acid, Megaloblastic anemia, Hypoglycemia. Tagipmet XR 100/1000mg (HCI) produces potentially life-threatening effects which include Lactic Acidosis. which are responsible for the discontinuation of Tagipmet XR 100/1000mg (HCI) therapy. The symptomatic adverse reactions produced by Tagipmet XR 100/1000mg (HCI) are more or less tolerable and if they become severe, they can be treated symptomatically, these include Abdominal distension, Flatulence, Nausea, Vomiting, Anorexia, Diarrhea, Skin reactions, Weight LossX, Hypersensitivity, Metallic taste.

Warnings

• Tagipmet XR 100/1000mg should be used with caution in patients with pre-existing liver disease, kidney disease, heart trouble or if have any allergy, infections. Avoid excessive use of alcohol while taking this. It is not recommended for use during pregnancy and should be used only if clearly needed during lactation.